New gel stent shows promise for glaucoma patients
NCT ID NCT05411198
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a gel stent implant for open-angle glaucoma, a leading cause of blindness. 74 adults aged 45+ received the implant and were followed for 12 months. The goal was to safely lower eye pressure and reduce the need for glaucoma medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Sight - Sarasota /ID# 227577
Sarasota, Florida, 34239, United States
-
East Coast Institute for Research /ID# 255508
Jacksonville, Florida, 32256-9680, United States
-
El Paso Eye Surgeons, P.A. /ID# 227575
El Paso, Texas, 79902, United States
-
Eye Surgery Associates /ID# 252207
East Melbourne, Victoria, 3002, Australia
-
Eye associates /ID# 227572
San Antonio, Texas, 78229, United States
-
Fichte Endl & Elmer Eyecare /ID# 245165
Niagara Falls, New York, 14304, United States
-
Georgia Eye Partners /ID# 245203
Atlanta, Georgia, 30342, United States
-
Glaucoma Associates of Texas /ID# 227580
Dallas, Texas, 75231, United States
-
Kremer Eye Center - King of Prussia /ID# 245573
King of Prussia, Pennsylvania, 19406, United States
-
Melbourne Eye Specialists /ID# 252353
Fitzroy, Victoria, VIC3065, Australia
-
NYU Langone Medical Center /ID# 227583
New York, New York, 10016-6402, United States
-
New Vision Eye Center /ID# 261053
Vero Beach, Florida, 32960-6551, United States
-
Northern Virginia Ophthalmology Associates -Falls Church /ID# 246925
Falls Church, Virginia, 22042-3013, United States
-
Oklahoma Eye Surgeons /ID# 246840
Oklahoma City, Oklahoma, 73112, United States
-
Ophthalmic Partners, PC /ID# 245367
Bala-Cynwyd, Pennsylvania, 19004, United States
-
Stiles Eyecare Excellence /ID# 227576
Overland Park, Kansas, 66213, United States
-
The Johns Hopkins Wilmer Eye Institute - Bethesda /ID# 245355
Bethesda, Maryland, 20817, United States
-
UCLA Doheny Eye Center /ID# 227587
Pasadena, California, 91105, United States
-
University of Texas Southwestern Medical Center /ID# 246848
Dallas, Texas, 75390-7208, United States
-
University of Utah /ID# 245324
Salt Lake City, Utah, 84112-5500, United States
-
Vance Thompson Vision /ID# 260892
Sioux Falls, South Dakota, 57108, United States
-
Vance Thompson Vision /ID# 261125
Alexandria, Minnesota, 56308-3408, United States
-
Ventura Ophthalmology /ID# 227585
Ventura, California, 93003, United States
-
Vold Vision /ID# 245285
Fayetteville, Arkansas, 72704, United States
-
Washington University-School of Medicine /ID# 245452
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Eye scan may spot hidden blood-flow changes that signal glaucoma risk in diabetes
- Eye implant could offer long-term pressure control for glaucoma patients
- Glaucoma implant MINIject put to the test in everyday eye clinics
- Glaucoma implant could replace daily eye drops
- Glaucoma supplement trial fizzles: MEMOPTIC study halted early
- Glaucoma implant under the microscope: 5-Year safety watch begins